ISRAEL 
HIGH-TECH & INVESTMENT REPORT

from the October 2013 issue


BioLineRX obtains FDA orphan drug status for leukemia drug

The company has obtained orphan drugs designation for BL-8040 as a therapeutic for the treatment of acute myeloid leukemia.



Reprinted from the Israel High-Tech & Investment Report October 2013

Click HERE to request further information.
Click HERE to go BACK.